Hot Topics in Pediatric Infectious Diseases

Dr. Deborah Lehman will review pediatric infectious disease hot topics for the general practitioner.  Learners will hear updates on the COVID-19 pandemic, measles and the state of vaccine hesitancy.

Learning Objectives

  • Discuss the current COVID-19 pandemic with respect to pediatrics.
  • Recognize the effectiveness of different approaches to vaccine hesitant families.
  • Describe the recent measles outbreaks in the United States and recognize the risks for future outbreaks.

Additional Information

Partner: 
Pri-Med
State Relevance: 
Alabama Requirement
District of Columbia Requirement
Hawaii Requirement
Idaho Requirement
Illinois Requirement
Indiana Requirement
Kentucky Requirement
Pennsylvania Requirement
South Carolina Requirement
Texas Requirement
Virginia Requirement
West Virginia Requirement
Course summary
Available credit: 
  • 1.00 AANP Contact Hours
    • 0.50 Pharmacology
  • 0.50 AANP Pharmacology Contact Hours
  • 1.00 MOC
  • 1.00 AMA PRA Category 1 Credit
Course opens: 
09/10/2021
Course expires: 
09/10/2022
Rating: 
0

Deborah Lehman, MD

Clinical Professor of Pediatrics
David Geffen School of Medicine at UCLA
Los Angeles, CA

Disclosures

The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.

Deborah Lehman, MD: No relevant financial relationships disclosed.

Martin A. Quan, MD (moderator): No relevant financial relationships disclose.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

AMA PRA Category 1 Credits

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Pri-Med Institute and the David Geffen School of Medicine at UCLA. Pri-Med Institute is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number 040308.

Designation Statement

This activity is approved for 1.00 contact hour of continuing education, which includes 0.50 hour of pharmacology.

Instructions for Obtaining Credit

Once you have completed the activity, please click the "next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer 2 out of the 3 questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and have the opportunity to review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen. For PAs, the NCCPA accepts for Category 1 CME credit activities designated for AMA PRA Category 1 Credit.

Available Credit

  • 1.00 AANP Contact Hours
    • 0.50 Pharmacology
  • 0.50 AANP Pharmacology Contact Hours
  • 1.00 MOC
  • 1.00 AMA PRA Category 1 Credit
Please login or register to take this course.

This course is offered through Pri-Med. 

To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!

 

Topics

COVID-19,  Infectious DiseasesPharmacotherapeutics, Pharmacology